1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijpmbs@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers.[Read More]
 

C-Reactive Protein as a Guide for he Treatment Response of Opportunistic Infections In HIV

Kala Yadhav M L and Nagesh Y Wadgera
Department of Microbiology, BMCRI, Bangalore, India.
Abstract—CRP is an acute phase protein whose levels increase with the infection and inflammation. The present study was conducted at Victoria Hospital Bangalore, where a total of 171 HIV patients were enrolled with a note on their opportunistic infections (OI), CRP level and treatment history of the underlying OI. 58 asymptomatic patients acted as control with CRP level less than 6 mg/L, showing no base line rise in CRP. Of the 86 tuberculosis patients, 23 had no history of treatment and CRP was found to be 41.2 mg/L. 3 patients of TB, with 1 day treatment history, had a mean CRP of about 36.6mg/L. 6 patients of TB, with a treatment history of 2days, showed a mean CRP of about 17 mg/L. 7 patients with 3 days treatment history, showed a mean CRP of 10.7mg/L. A graph of CRP and no of days of treatment, showed a negative correlation (r = ¨C0.2427) between them. Graphically it was found that, CRP elevated on or after 23 days of treatment of underlying OI could indicatetreatment failure. CRP can be used as an indicator for the treatment response of the underlying OI in HIV positive patients.

Index Terms—Opportunistic infections, CRP, Tuberculosis

Cite: Kala Yadhav M L and Nagesh Y Wadgera, "C-Reactive Protein as a Guide for he Treatment Response of Opportunistic Infections In HIV," International Journal of Pharma Medicine and Biological Sciences, Vol. 1, No. 2, pp. 159-165, October 2012.
Copyright © 2012-2019 International Journal of Pharma Medicine and Biological Sciences, All Rights Reserved
E-mail: ijpmbs@ejournal.net